New diabetes drug proven safe

The potentially market-altering diabetes drug SRT501, developed by Sirtris pharmaceuticals, has been proven safe in its first phase clinical trials . Whether the drug is effective remains to be seen.
Speaking at the JP Morgan Health Care Conference, the MD of Sirtris Christoph Westphal made it clear that there were no safety issues. The drug, which is a reformulation of resveratrol, the red wine ingredient known for its health properties, has attracted considerable interest from investors .
The second half of this year will see phase 2 date being released, in which the efficiency of the drug will be tested. The drug, taken orally, could compete if it proven to react well with Metformin. Sirtris are clear that they have other, better drugs in their pipeline.